The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation

Journal of Cell Biology

Volumn 190, Issue 1, 2010, Pages 129-141

  Kuang, Zhihe ^a   Lewis, Rowena S ^a   Curtis, Joan M ^a   Zhan, Yifan ^a   Saunders, Bernadette M ^b   Babon, Jeffrey J ^a   Kolesnik, Tatiana B ^a   Low, Andrew ^a   Masters, Seth L ^a   Willson, Tracy A ^a   Kedzierski, Lukasz ^a   Yao, Shenggen ^a   Handman, Emanuela ^a   Norton, Raymond S ^a   Nicholson, Sandra E ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b CENTENARY INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; POLYUBIQUITIN; PROTEASOME; REACTIVE NITROGEN SPECIES; REGULATOR PROTEIN; SOCS BOX PROTEIN 2; SUPPRESSOR OF CYTOKINE SIGNALING; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; COMPLEX FORMATION; CONTROLLED STUDY; GENE MUTATION; IMMUNE RESPONSE; LEISHMANIA MAJOR; MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTOZOAL INFECTION;

ANIMALS; CELL LINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; MICE; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE SYNTHASE TYPE II; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

LEISHMANIA MAJOR; MYCOBACTERIUM TUBERCULOSIS;

EID: 77954709822     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200912087     Document Type: Article

References (66)

1. Alderton, W.K., C.E. Cooper, and R.G. Knowles. 2001. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357:593-615. doi:10.1042/0264-6021:3570593 (Pubitemid 32735142)
2. Bartels, C., T.H. Xia, M. Billeter, P. Güntert, and K. Wüthrich. 1995. The program XEASY for computer-supported NMR spectral-analysis of biological macromolecules. J. Biomol. NMR. 6:1-10. doi:10.1007/BF00417486
3. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2:907-916. doi:10.1038/ni1001-907
4. Bogdan, C. 2008. Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. Cell. Microbiol. 10:1221-1234. doi:10.1111/j.1462-5822.2008.01146.x (Pubitemid 351663916)
5. Bogdan, C., M. Röllinghoff, and A. Diefenbach. 2000. The role of nitric oxide in innate immunity. Immunol. Rev. 173:17-26. doi:10.1034/j.1600- 065X.2000.917307.x (Pubitemid 30095207)
6. Chakravortty, D., and M. Hensel. 2003. Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect. 5:621-627. doi:10.1016/S1286-4579(03)00096-0 (Pubitemid 36645122)
7. Chan, E.D., J. Chan, and N.W. Schluger. 2001. What is the role of nitric oxide in murine and human host defense against tuberculosis?Current knowledge. Am. J. Respir. Cell Mol. Biol. 25:606-612.
8. Cnop, M., N. Welsh, J.C. Jonas, A. Jörns, S. Lenzen, and D.L. Eizirik. 2005. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes. 54:S97-S107. doi:10.2337/diabetes.54.suppl-2.S97 (Pubitemid 43343337)
9. Colton, C.A., M.P. Vitek, D.A. Wink, Q. Xu, V. Cantillana, M.L. Previti, W.E. Van Nostrand, J.B. Weinberg, B. Weinberg, and H. Dawson. 2006. NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 103:12867-12872. doi:10.1073/pnas. 0601075103
10. Copin, R., P. De Baetselier, Y. Carlier, J.J. Letesson, and E. Muraille. 2007. MyD88-dependent activation of B220-CD11b+LY-6C+ dendritic cells during Brucella melitensis infection. J. Immunol. 178:5182-5191.
11. Corr, S.C., and L.A. O'Neill. 2009. Listeria monocytogenes infection in the face of innate immunity. Cell. Microbiol. 11:703-709. doi:10.1111/j.1462- 5822.2009.01294.x
12. Croker, B.A., H. Kiu, and S.E. Nicholson. 2008. SOCS regulation of the JAK/STAT signalling pathway. Semin. Cell Dev. Biol. 19:414-422. doi:10.1016/j.semcdb.2008.07.010
13. de Castro, E., C.J. Sigrist, A. Gattiker, V. Bulliard, P.S. Langendijk-Genevaux, E. Gasteiger, A. Bairoch, and N. Hulo. 2006. ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins. Nucleic Acids Res. 34:W362-W365. doi:10.1093/nar/gkl124 (Pubitemid 44538121)
14. De Trez, C., S. Magez, S. Akira, B. Ryffel, Y. Carlier, and E. Muraille. 2009. iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice. PLoS Pathog. 5:e1000494. doi:10.1371/journal.ppat.1000494
15. Diefenbach, A., H. Schindler, N. Donhauser, E. Lorenz, T. Laskay, J. MacMicking, M. Röllinghoff, I. Gresser, and C. Bogdan. 1998. Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity. 8:77-87. doi:10.1016/S1074- 7613(00)80460-4 (Pubitemid 28097825)
16. Dimitriou, I.D., L. Clemenza, A.J. Scotter, G. Chen, F.M. Guerra, and R. Rottapel. 2008. Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol. Rev. 224:265-283. doi:10.1111/j.1600-065X.2008.00659.x
17. Dosztányi, Z., V. Csizmok, P. Tompa, and I. Simon. 2005. IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content. Bioinformatics. 21:3433-3434. doi:10.1093/bioinformatics/bti541 (Pubitemid 41222453)
18. DuBridge, R.B., P. Tang, H.C. Hsia, P.M. Leong, J.H. Miller, and M.P. Calos. 1987. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:379-387.
19. Flynn, J.L., C.A. Scanga, K.E. Tanaka, and J. Chan. 1998. Effects of aminoguanidine on latent murine tuberculosis. J. Immunol. 160:1796-1803.
20. Fukumura, D., S. Kashiwagi, and R.K. Jain. 2006. The role of nitric oxide in tumour progression. Nat. Rev. Cancer. 6:521-534. doi:10.1038/nrc1910 (Pubitemid 43980541)
21. Garvey, E.P., J.A. Oplinger, E.S. Furfine, R.J. Kiff, F. Laszlo, B.J. Whittle, and R.G. Knowles. 1997. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 272:4959-4963. doi:10.1074/jbc.272.8.4959
22. Gómez, L.M., J.M. Anaya, J.R. Vilchez, J. Cadena, R. Hinojosa, L. Vélez, M.A. Lopez-Nevot, and J. Martín. 2007. A polymorphism in the inducible nitric oxide synthase gene is associated with tuberculosis. Tuberculosis (Edinb.). 87:288-294. doi:10.1016/j.tube.2007.03.002 (Pubitemid 46938689)
23. Hershko, A., and A. Ciechanover. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425-479. doi:10.1146/annurev.biochem.67.1.425
24. Hilton, D.J., R.T. Richardson, W.S. Alexander, E.M. Viney, T.A. Willson, N.S. Sprigg, R. Starr, S.E. Nicholson, D. Metcalf, and N.A. Nicola. 1998. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA. 95:114-119. doi:10.1073/pnas.95.1.114
25. Kamura, T., S. Sato, D. Haque, L. Liu, W.G. Kaelin Jr., R.C. Conaway, and J.W. Conaway. 1998. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12:3872-3881. doi:10.1101/gad.12.24.3872 (Pubitemid 29024849)
26. Knowles, R.G., and S. Moncada. 1994. Nitric oxide synthases in mammals. Biochem. J. 298:249-258.
27. Kolodziejski, P.J., A. Musial, J.S. Koo, and N.T. Eissa. 2002. Ubiquitination of inducible nitric oxide synthase is required for its degradation. Proc. Natl. Acad. Sci. USA. 99:12315-12320. doi:10.1073/pnas. 192345199
28. Kolodziejski, P.J., J.S. Koo, and N.T. Eissa. 2004. Regulation of inducible nitric oxide synthase by rapid cellular turnover and cotranslational down-regulation by dimerization inhibitors. Proc. Natl. Acad. Sci. USA. 101:18141-18146. doi:10.1073/pnas.0406711102
29. Korbel, D.S., B.E. Schneider, and U.E. Schaible. 2008. Innate immunity in tuberculosis: myths and truth. Microbes Infect. 10:995-1004. doi:10.1016/j.micinf.2008.07.039
30. Kröncke, K.D., K. Fehsel, and V. Kolb-Bachofen. 1998. Inducible nitric oxide synthase in human diseases. Clin. Exp. Immunol. 113:147-156. doi:10.1046/j.1365-2249.1998.00648.x (Pubitemid 28352831)
31. Kuang, Z., S. Yao, Y. Xu, R.S. Lewis, A. Low, S.L. Masters, T.A. Willson, T.B. Kolesnik, S.E. Nicholson, T.J. Garrett, and R.S. Norton. 2009. SPRY domain-containing SOCS box protein 2: crystal structure and residues critical for protein binding. J. Mol. Biol. 386:662-674. doi:10.1016/j.jmb.2008.12.078
32. Laubach, V.E., E.G. Shesely, O. Smithies, and P.A. Sherman. 1995. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA. 92:10688-10692. doi:10.1073/pnas.92.23.10688
33. Liese, J., U. Schleicher, and C. Bogdan. 2008. The innate immune response against Leishmania parasites. Immunobiology. 213:377-387. doi:10.1016/j.imbio. 2007.12.005
34. MacMicking, J.D., C. Nathan, G. Hom, N. Chartrain, D.S. Fletcher, M. Trumbauer, K. Stevens, Q.W. Xie, K. Sokol, N. Hutchinson, et al. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:641-650. doi:10.1016/0092-8674(95)90085-3
35. MacMicking, J.D., R.J. North, R. LaCourse, J.S. Mudgett, S.K. Shah, and C.F. Nathan. 1997a. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA. 94:5243-5248. doi:10.1073/pnas.94.10.5243 (Pubitemid 27214768)
36. MacMicking, J., Q.W. Xie, and C. Nathan. 1997b. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350. doi:10.1146/annurev. immunol.15.1.323
37. Masters, S.L., K.R. Palmer, W.S. Stevenson, D. Metcalf, E.M. Viney, N.S. Sprigg, W.S. Alexander, N.A. Nicola, and S.E. Nicholson. 2005. Genetic deletion of murine SPRY domain-containing SOCS box protein 2 (SSB-2) results in very mild thrombocytopenia. Mol. Cell. Biol. 25:5639-5647. doi:10.1128/MCB.25.13.5639- 5647.2005
38. Masters, S.L., S. Yao, T.A. Willson, J.G. Zhang, K.R. Palmer, B.J. Smith, J.J. Babon, N.A. Nicola, R.S. Norton, and S.E. Nicholson. 2006. The SPRY domain of SSB-2 adopts a novel fold that presents conserved Par-4-binding residues. Nat. Struct. Mol. Biol. 13:77-84. doi:10.1038/nsmb1034
39. Musial, A., and N.T. Eissa. 2001. Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway. J. Biol. Chem. 276:24268-24273. doi:10.1074/jbc.M100725200
40. Nathan, C., and Q.W. Xie. 1994a. Nitric oxide synthases: roles, tolls, and controls. Cell. 78:915-918. doi:10.1016/0092-8674(94)90266-6 (Pubitemid 24292319)
41. Nathan, C., and Q.W. Xie. 1994b. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:13725-13728.
42. Nathan, C., N. Calingasan, J. Nezezon, A. Ding, M.S. Lucia, K. La Perle, M. Fuortes, M. Lin, S. Ehrt, N.S. Kwon, et al. 2005. Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase. J. Exp. Med. 202:1163-1169. doi:10.1084/jem.20051529
43. Nicholson, S.E., and D.J. Hilton. 1998. The SOCS proteins: a new family of negative regulators of signal transduction. J. Leukoc. Biol. 63:665-668.
44. Nicholson, S.E., U. Novak, S.F. Ziegler, and J.E. Layton. 1995. Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK. Blood. 86:3698-3704.
45. Nicholson, S., Mda.G. Bonecini-Almeida, J.R. Lapa e Silva, C. Nathan, Q.W. Xie, R. Mumford, J.R. Weidner, J. Calaycay, J. Geng, N. Boechat, et al. 1996. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 183:2293-2302. doi:10.1084/jem.183.5. 2293
46. Petroski, M.D., and R.J. Deshaies. 2005. Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 6:9-20. doi:10.1038/nrm1547 (Pubitemid 40064895)
47. Prado, C.M., E.A. Leick-Maldonado, L. Yano, A.S. Leme, V.L. Capelozzi, M.A. Martins, and I.F. Tibério. 2006. Effects of nitric oxide synthases in chronic allergic airway inflammation and remodeling. Am. J. Respir. Cell Mol. Biol. 35:457-465. doi:10.1165/rcmb.2005-0391OC
48. Prilusky, J., C.E. Felder, T. Zeev-Ben-Mordehai, E.H. Rydberg, O. Man, J.S. Beckmann, I. Silman, and J.L. Sussman. 2005. FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics. 21:3435-3438. doi:10.1093/bioinformatics/bti537 (Pubitemid 41222454)
49. Ricciardolo, F.L., P.J. Sterk, B. Gaston, and G. Folkerts. 2004. Nitric oxide in health and disease of the respiratory system. Physiol. Rev. 84:731-765. doi:10.1152/physrev.00034.2003 (Pubitemid 38823765)
50. Scott, C.L., L. Roe, J. Curtis, T. Baldwin, L. Robb, C.G. Begley, and E. Handman. 2000. Mice unresponsive to GM-CSF are unexpectedly resistant to cutaneous Leishmania major infection. Microbes Infect. 2:1131-1138. doi:10.1016/S1286-4579(00)01267-3
51. Serbina, N.V., T.P. Salazar-Mather, C.A. Biron, W.A. Kuziel, and E.G. Pamer. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity. 19:59-70. doi:10.1016/S1074-7613(03) 00171-7
52. Stuehr, D.J., and C.F. Nathan. 1989. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1543-1555. doi:10.1084/jem.169.5.1543
53. Styhler, S., A. Nakamura, and P. Lasko. 2002. VASA localization requires the SPRY-domain and SOCS-box containing protein, GUSTAVUS. Dev. Cell. 3:865-876. doi:10.1016/S1534-5807(02)00361-1 (Pubitemid 35460786)
54. Tezuka, H., Y. Abe, M. Iwata, H. Takeuchi, H. Ishikawa, M. Matsushita, T. Shiohara, S. Akira, and T. Ohteki. 2007. Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature. 448:929-933. doi:10.1038/nature06033 (Pubitemid 47312771)
55. Wang, D., Z. Li, E.M. Messing, and G. Wu. 2005. The SPRY domain-containing SOCS box protein 1 (SSB-1) interacts with MET and enhances the hepatocyte growth factor-induced Erk-Elk-1-serum response element pathway. J. Biol. Chem. 280:16393-16401. doi:10.1074/jbc.M413897200
56. Wei, X.Q., I.G. Charles, A. Smith, J. Ure, G.J. Feng, F.P. Huang, D. Xu, W. Muller, S. Moncada, and F.Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:408-411. doi:10.1038/375408a0
57. Wishart, D.S., C.G. Bigam, J. Yao, F. Abildgaard, H.J. Dyson, E. Oldfield, J.L. Markley, and B.D. Sykes. 1995. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J. Biomol. NMR. 6:135-140. doi:10.1007/ BF00211777
58. Woo, J.S., H.Y. Suh, S.Y. Park, and B.H. Oh. 2006. Structural basis for protein recognition by B30.2/SPRY domains. Mol. Cell. 24:967-976. doi:10.1016/j.molcel.2006.11.009
59. Wormald, S., J.G. Zhang, D.L. Krebs, L.A. Mielke, J. Silver, W.S. Alexander, T.P. Speed, N.A. Nicola, and D.J. Hilton. 2006. The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling. J. Biol. Chem. 281:11135-11143. doi:10.1074/jbc.M509595200 (Pubitemid 43855538)
60. Wu, G., and S.M. Morris Jr. 1998. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336:1-17. (Pubitemid 28532555)
61. Xiong, Q., Y. Tezuka, T. Kaneko, H. Li, L.Q. Tran, K. Hase, T. Namba, and S. Kadota. 2000. Inhibition of nitric oxide by phenylethanoids in activated macrophages. Eur. J. Pharmacol. 400:137-144. doi:10.1016/S0014-2999(00)00354-X (Pubitemid 30412119)
62. Yao, S., S.L. Masters, J.G. Zhang, K.R. Palmer, J.J. Babon, N.A. Nicola, S.E. Nicholson, and R.S. Norton. 2005. Backbone 1H, 13C and 15N assignments of the 25 kDa SPRY domain-containing SOCS box protein 2 (SSB-2). J. Biomol. NMR. 31:69-70. doi:10.1007/s10858-004-6924-6
63. Yao, S., M.S. Liu, S.L. Masters, J.G. Zhang, J.J. Babon, N.A. Nicola, S.E. Nicholson, and R.S. Norton. 2006. Dynamics of the SPRY domain-containing SOCS box protein 2: flexibility of key functional loops. Protein Sci. 15:2761-2772. doi:10.1110/ps.062477806 (Pubitemid 44833757)
64. Zhan, Y., and C. Cheers. 1998. Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors. J. Immunol. 161:1447-1453. (Pubitemid 28380576)
65. Zhang, J.G., D. Metcalf, S. Rakar, M. Asimakis, C.J. Greenhalgh, T.A. Willson, R. Starr, S.E. Nicholson, W. Carter, W.S. Alexander, et al. 2001. The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo. Proc. Natl. Acad. Sci. USA. 98:13261-13265. doi:10.1073/pnas.231486498
66. Zheng, N., B.A. Schulman, L. Song, J.J. Miller, P.D. Jeffrey, P. Wang, C. Chu, D.M. Koepp, S.J. Elledge, M. Pagano, et al. 2002. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature. 416:703-709. doi:10.1038/416703a